These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 22503660

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications.
    Liu J, Zhang X, Cao X.
    J Autoimmun; 2022 Oct; 132():102856. PubMed ID: 35773101
    [Abstract] [Full Text] [Related]

  • 27. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P, Wu J, Liu S, Han X, Lu J, Shi Y, Wang J, Lu L, Cao X.
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [Abstract] [Full Text] [Related]

  • 28. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection.
    Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, Yakushijin T, Oki C, Itose I, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    J Infect Dis; 2004 Dec 01; 190(11):1919-26. PubMed ID: 15529255
    [Abstract] [Full Text] [Related]

  • 29. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
    Scheinecker C, Zwölfer B, Köller M, Männer G, Smolen JS.
    Arthritis Rheum; 2001 Apr 01; 44(4):856-65. PubMed ID: 11315925
    [Abstract] [Full Text] [Related]

  • 30. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.
    Biermann MH, Veissi S, Maueröder C, Chaurio R, Berens C, Herrmann M, Munoz LE.
    Expert Rev Clin Immunol; 2014 Sep 01; 10(9):1151-64. PubMed ID: 25081199
    [Abstract] [Full Text] [Related]

  • 31. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus.
    Ding D, Mehta H, McCune WJ, Kaplan MJ.
    J Immunol; 2006 Nov 01; 177(9):5878-89. PubMed ID: 17056512
    [Abstract] [Full Text] [Related]

  • 32. Advances in mechanisms of systemic lupus erythematosus.
    Dema B, Charles N.
    Discov Med; 2014 May 01; 17(95):247-55. PubMed ID: 24882716
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S, Guri KM, Elbirt D, Asher I, Sthoeger ZM.
    Isr Med Assoc J; 2014 Apr 01; 16(4):246-9. PubMed ID: 24834763
    [Abstract] [Full Text] [Related]

  • 39. Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
    Banchereau J, Pascual V.
    Immunity; 2006 Sep 01; 25(3):383-92. PubMed ID: 16979570
    [Abstract] [Full Text] [Related]

  • 40. Dendritic cells control B cell growth and differentiation.
    Jego G, Pascual V, Palucka AK, Banchereau J.
    Curr Dir Autoimmun; 2005 Sep 01; 8():124-39. PubMed ID: 15564719
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.